Existing studies on the neonatal effects of drug exposure in utero are subject to many confounding factors. Many studies have relied on the history obtained from the mother, which is notoriously inaccurate. In addition to recall bias, there is a considerable incentive to withhold information. Testing of urine for drugs of abuse does not reflect drug exposure throughout pregnancy and does not provide quantitative information. Many women who abuse drugs are multiple drug abusers and also drink alcohol and smoke cigarettes. It is thus difficult to isolate the effects of any one drug. Social and economic deprivation is common among drug abusers, and this factor not only confounds perinatal data but has a major effect on long-term studies of infant outcome.
I. Definition. An infant of a drug-abusing mother (IDAM) is one whose mother has taken drugs that may potentially cause neonatal withdrawal symptoms. The constellation of signs and symptoms associated with withdrawal is called the neonatal withdrawal syndrome. Table 95–1 lists the drugs associated with this syndrome.
II. Incidence. Maternal drug abuse has increased over the past decade. It is estimated that ~5–10% of deliveries nationwide are to women who have abused drugs (excluding alcohol) during pregnancy. The incidence is considerably higher in inner-city hospitals.
III. Pathophysiology. Drugs of abuse are of low molecular weight and usually water soluble and lipophilic. These features facilitate their transfer across the placenta and accumulation in the fetus and amniotic fluid. The half-life of drugs is usually prolonged in the fetus compared with an adult. Most drugs of abuse either bind to various central nervous system (CNS) receptors or affect the release and reuptake of various neurotransmitters. This may have a long-lasting trophic effect on developing dendritic structures. In addition, some drugs are directly toxic to fetal cells. The developing fetus may also be affected by the direct physiologic effects of a drug. Many of the fetal effects of cocaine, including its putative teratogenic effects, are thought to be due to its potent vasoconstrictive property.
Some drugs appear to have a partially beneficial effect. The incidence of respiratory distress syndrome (RDS) is decreased after maternal use of heroin and possibly also cocaine. These effects are probably a reflection of fetal stress rather than a direct maturational effect of these drugs. Particularly in the case of cocaine, the decreased incidence of RDS is more than offset by the considerable increase in preterm deliveries after its use. The major concern in IDAMs is the long-term outcome. The importance of direct and indirect effects of drugs on the developing CNS predominates, and the risks of drug abuse far outweigh the benefits. Pathophysiology of specific drugs are:
A. Opiates. Opiates bind to opiate receptors in the CNS; part of the clinical manifestations of narcotic withdrawal result from α2-adrenergic super-sensitivity (particularly in the locus ceruleus).
B. Cocaine. Cocaine prevents the reuptake of neurotransmitters (epinephrine, norepinephrine, dopamine, and serotonin) at nerve endings and causes a supersensitivity or exaggerated response ...
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.